Short answer · Medically reviewed summary · Last updated: 2026-05-08
Polymyalgia rheumatica was first described in the medical literature in 1888 by William Bruce, though it was not formally named until 1957. Since its discovery, our understanding of Polymyalgia rheumatica has evolved from a vague "senile rheumatic gout" to a well-defined inflammatory condition primarily managed with low-dose corticosteroids. When was Polymyalgia rheumatica first identified? The first clinical description of Polymyalgia rheumatica appeared in 1888 when Dr.
What is the history of Polymyalgia Rheumatica?
History of Polymyalgia Rheumatica: when and how it was discovered, and the milestones in research since, medically reviewed.
Polymyalgia rheumatica was first described in the medical literature in 1888 by William Bruce, though it was not formally named until 1957. Since its discovery, our understanding of Polymyalgia rheumatica has evolved from a vague "senile rheumatic gout" to a well-defined inflammatory condition primarily managed with low-dose corticosteroids.
When was Polymyalgia rheumatica first identified?
The first clinical description of Polymyalgia rheumatica appeared in 1888 when Dr. William Bruce reported a patient with "senile rheumatic gout." For decades, the condition was shrouded in confusion, often misdiagnosed as simple aging or arthritis. It wasn't until 1957 that Dr. M.D. Barber and colleagues coined the term Polymyalgia rheumatica to accurately capture the hallmark muscle pain and stiffness associated with the disease.
How has the understanding of the condition evolved?
Historically, physicians struggled to distinguish Polymyalgia rheumatica from giant cell arteritis (GCA), a related condition involving inflammation of the blood vessels. Today, we recognize that approximately 15% to 20% of patients with Polymyalgia rheumatica also have concurrent GCA. Modern advancements in ultrasound and PET imaging have revolutionized our ability to visualize the inflammation in the shoulders, hips, and bursae, moving us away from purely clinical diagnosis toward objective, imaging-based confirmation.
What are the major milestones in treatment?
The management of Polymyalgia rheumatica changed forever in the mid-20th century with the advent of corticosteroids. Before this, patients often suffered for years with debilitating stiffness. Key treatment milestones include:
- 1950s: The introduction of corticosteroids as the gold-standard treatment, providing rapid relief from symptoms.
- Late 20th Century: Development of standardized tapering protocols to minimize long-term steroid side effects.
- Modern Era: The exploration of steroid-sparing agents, such as interleukin-6 inhibitors, for patients who cannot tolerate traditional therapy.
Next steps
- Consult a rheumatologist to confirm your diagnosis through blood markers like ESR and CRP.
- Join the 52 members of the DiseaseMaps.org community to share experiences with Polymyalgia rheumatica.
- Keep a symptom journal to track your response to treatment and share it with your healthcare provider.
Medical disclaimer: This content is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- Orphanet: Rare Disease Database
- American College of Rheumatology (ACR) Guidelines
- PubMed: Historical perspectives on rheumatic diseases
